Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in $5 Million Public Offering of CEL-SCI By Sichenzia Ross Ference LLP | December 30, 2024 Cel-Sci Corp. $5,000,000 Public Offering December 2024 Read More
Sichenzia Ross Ference Carmel LLP Represents Nature’s Miracle Holding Inc. in Closing of $3 Million Public Offering By Sichenzia Ross Ference LLP | November 15, 2024 Nature’s Miracle Holding Inc. $4,000,000 Public Offering November 2024 Read More
Sichenzia Ross Ference Carmel LLP Represents ShiftPixy, Inc. in $5.0 Million Public Offering By Sichenzia Ross Ference LLP | March 25, 2024 ShiftPixy, Inc. $5,000,000 Public Offering March 2024 Read More
Sichenzia Ross Ference Carmel LLP Represents ThinkEquity LLC and Laidlaw & Company (UK) Ltd. in a $2.1 Million underwritten Public Offering By Sichenzia Ross Ference LLP | March 6, 2024 Oragenics Inc. $2,100,000 Common Stock March 2024 Read More
Sichenzia Ross Ference Carmel LLP Represents Sunshine Biopharma, Inc. in $10.0 Million Underwritten Public Offering of Common Stock By Sichenzia Ross Ference LLP | February 16, 2024 Sunshine Biopharma, Inc. $10,000,000 Common Stock and Warrants February 2024 Read More
Sichenzia Ross Ference Carmel LLP Represents Spartan Capital Securities, LLC in $8.45 Million Private Offering of Alpha Cognition, Inc. By Sichenzia Ross Ference LLP | January 24, 2024 Alpha Cognition, Inc. $8,450,000 Public Offering January 2024 Read More
Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $7 Million Public Offering of C3is Inc. By Sichenzia Ross Ference LLP | January 23, 2024 C3is, Inc. $7,000,000 Public Offering January 2024 Read More
Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $5.0 Million Private Placement of SciSparc Ltd. By Sichenzia Ross Ference LLP | October 17, 2023 SciSparc Ltd. Private Placement October 2023 Read More
Sichenzia Ross Ference Carmel LLP Represents ShiftPixy, Inc. in $2.5 Million Registered Direct Offering and Concurrent Private Placement By Sichenzia Ross Ference LLP | October 11, 2023 ShiftPixy, Inc. $2,500,000 Common Stock Warrants October 2023 Read More
Sichenzia Ross Ference LLP Represents Biotricity, Inc. in $2 Million Sale of Series B Preferred Stock By Sichenzia Ross Ference LLP | September 21, 2023 Biotricity, Inc. $2,000,000 Series B Preferred Stock September 2023 Read More